| results < retention < rethinking | Facettes : |
List of bibliographic references
Number of relevant bibliographic references: 2.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000432 (2020) | Kosuke Ebina [Japon] ; Toru Hirano [Japon] ; Yuichi Maeda [Japon] ; Wataru Yamamoto [Japon] ; Motomu Hashimoto [Japon] ; Koichi Murata [Japon] ; Tohru Takeuchi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Akira Onishi [Japon] ; Sadao Jinno [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Keiichi Yamamoto [Japon] ; Atsushi Kumanogoh [Japon] ; Makoto Hirao [Japon] | Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study. |
| 000433 (2020) | Corrado Campochiaro [Italie] ; Alessandro Tomelleri [Italie] ; Silvia Sartorelli [Italie] ; Giulio Cavalli [Italie] ; Giacomo De Luca [Italie] ; Elena Baldissera [Italie] ; Lorenzo Dagna [Italie] | Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "retention"
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i \
-Sk "retention" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= 2020
|étape= Analysis
|type= indexItem
|index= Title.i
|clé= retention
}}
| This area was generated with Dilib version V0.6.34. |  |